Gsk (GSK) Cash & Equivalents (2009 - 2026)
Gsk (GSK) posted Cash & Equivalents of $4.17 billion for the quarter ended Jun 30, 2026, down 13.2% from $4.8 billion a year earlier and down 10.2% from the prior quarter.
Powered by 
Analysis
Gsk (GSK) Cash & Equivalents (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Gsk's Cash & Equivalents came in at $4.48 billion, down 9.5% from the prior year.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -11.1% (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Cash & Equivalents was $4.95 billion in the year ended Dec 31, 2024 (+35.5%), $3.65 billion in the year ended Dec 31, 2023 (-20.7%), $4.61 billion in the year ended Dec 31, 2022 (-21.6%) and $5.88 billion in the year ended Dec 31, 2021 (-27.2%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Cash & Equivalents since the quarter ended Sep 30, 2024.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last three quarters, with growth averaging 11.8% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was the quarter ended Mar 31, 2023, with growth of 585.3%; the weakest was the quarter ended Mar 31, 2022, with a decline of 92.2%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $4.64 billion (quarter ended Mar 31, 2026), $4.52 billion (quarter ended Dec 31, 2025) and $4.45 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 4.17 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.17 Bn |
| Mar 31, 2026 | 4.64 Bn |
| Dec 31, 2025 | 4.52 Bn |
| Sep 30, 2025 | 4.45 Bn |
| Jun 30, 2025 | 4.80 Bn |
| Mar 31, 2025 | 5.62 Bn |
| Dec 31, 2024 | 4.97 Bn |
| Sep 30, 2024 | 4.15 Bn |
| Jun 30, 2024 | 3.74 Bn |
| Mar 31, 2024 | 3.54 Bn |
| Dec 31, 2023 | 3.64 Bn |
| Sep 30, 2023 | 4.02 Bn |
| Jun 30, 2023 | 3.93 Bn |
| Mar 31, 2023 | 3.51 Bn |
| Dec 31, 2022 | 4.37 Bn |
| Sep 30, 2022 | 4.25 Bn |
| Jun 30, 2022 | 8.14 Bn |
| Mar 31, 2022 | 512.58 Mn |
| Dec 31, 2021 | 5.76 Bn |
| Sep 30, 2021 | 4.76 Bn |
API Access
Gsk Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();